Covaxin gets Brazilian regulator s conditional nod, Bharat Biotech to export four million doses
Covaxin gets Brazilian regulator s conditional nod, Bharat Biotech to export four million doses
Anvisa, also known as the The National Health Surveillance Agency of Brazil, has approved the import of Bharat Biotech s Covaxin and Russia s Sputnik V vaccine into that country.
advertisement
File photo of Bharat Biotech s Covid-19 vaccine - Covaxin (Photo Credits: PTI)
HIGHLIGHTS
Bharat Biotech had signed an agreement with Brazilian government on February 26
Anvisa also granted emergency use approval to Russian-made Sputnik V vaccine
Brazil has given clearance to the proposal to import Bharat Biotech s Covid-19 vaccine Covaxin into the South American country with some conditions.
La Agencia Sanitaria de Brasil aprueba la importación de la vacuna rusa Sputnik V contra el covid-19 rt.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from rt.com Daily Mail and Mail on Sunday newspapers.
Read more about Bharat Biotech gives request to Brazilian regulator for Covaxin approval on Business Standard. Earlier, Anvisa denied permission to import Covaxin after its authorities found that the plant in which the jab is being made did not meet the Good Manufacturing Practice (GMP) requirements
Anvisa had earlier denied permission to import Covaxin after its authorities found that the plant in which the jab is being made did not meet the Good Manufacturing Practice requirements.
Bharat Biotech has signed an agreement with Brazil for supply of 20 million doses of Covaxin.
Hyderabad:
Bharat Biotech which faced a red flag from Brazil s health regulator for supply of COVID-19 vaccine Covaxin to that country over the issues of Good Manufacturing Practices in its plant, has filed a new request to the Brazilian authorities for certification.
According to the National Health Surveillance Agency of Brazil Anvisa, Bharat Biotech made the request on May 25 and a day before the Ministry of Health of the South American country filed a new application for authorisation to import 20 million doses of the Covaxin.